Skip to content

Inhalational Anesthesia vs TIVA in Endoscopic Tympanoplasty

Comparison of Inhalational Anesthesia and Total Intravenous Anesthesia on Surgical Field Quality and Post-operative Recovery in Endoscopic Tympanoplasty

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05993039
Acronym
TIVA
Enrollment
100
Registered
2023-08-15
Start date
2023-09-01
Completion date
2024-12-31
Last updated
2023-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perforated Eardrum

Keywords

tympanoplasty, Inhalational anesthesia, total intravenous anesthesia, intraoperative blood loss

Brief summary

This study aims to prospectively compare surgical field quality and intraoperative blood loss between general inhalational anesthesia to total intravenous anesthesia (TIVA) alone in subjects undergoing endoscopic ear surgery. A secondary objective is to compare rates of emergence delirium and total recovery time between the two groups.

Detailed description

In sinus surgery, TIVA has been described as a possible advantage in the use of endoscopic ear surgery. However, to date, there are no studies that examine blood loss, surgical field quality, and recovery in TIVA compared to inhalational anesthesia in the setting of endoscopic ear surgery. The hypothesis is that in patients who undergo endoscopic tympanoplasty, those who receive TIVA will have reduced intraoperative blood loss, improved surgical field quality, and reduced emergence agitation than those who receive inhalational anesthesia. This study will be a prospective double-blinded randomized control trial consisting of subjects undergoing endoscopic tympanoplasty surgery to assess intraoperative blood loss, surgical field quality, rates of emergence delirium, and recovery time.

Interventions

1-2% adults 0.6-1.5% Children

1mg/kg-mcg/kg/min adults 100-200mcg/kg/min children

0.05-2ug/kg/min adults and children

Sponsors

Louisiana State University Health Sciences Center in New Orleans
CollaboratorOTHER
Our Lady of the Lake Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Masking description

In the operating room, in order to blind the surgeon to the type of anesthesia used, a surgical drape will be placed in between the subject and the anesthesia team to conceal the anesthesia machinery and equipment. A sham intravenous pole will be at the anesthesia workstation for those subjects in the control arm to contribute to the blinding of the surgeon. Patients will not be informed about which arm they are randomly assigned to and only the anesthesiologist will be aware prior to the surgery.

Intervention model description

double-blinded randomized control

Eligibility

Sex/Gender
ALL
Age
0 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Individuals of all ages * Scheduled to undergo an endoscopic tympanoplasty

Exclusion criteria

* Individuals with anticoagulation disorders * Those receiving anticoagulation therapy currently

Design outcomes

Primary

MeasureTime frameDescription
Surgical Field QualityPost-Operative evaluation (within 2 weeks)Neurotologists will evaluate endoscopic video clips from each surgery to assess clarity of field at different points in the surgery using the Boezaart scale grading system. It is a scale from 0-5, with 0 being the most favorable outcome and 5 being the least favorable outcome.
Intra-operative blood loss1-2 hours during surgeryIntraoperative blood loss will be determined by measuring the total number of pledgets needed to attain hemostatsis. This will be a general observation with the more pledgets needed to stop bleeding in the surgical area indicates more possible blood loss than the procedures with that require less pledgets.

Secondary

MeasureTime frameDescription
Emergent Delirium and Recovery Time-Riker ScaleImmediately After extubationSedation and agitation will be assessed immediately after extubation using the Riker Sedation-Agitation Scale (SAS) which is on scale of 1-7 with 1 being the most favorable (easier to rouse/calm but responsive) and 7 being the least favorable (deeply sedated/higher agitation).
Emergent Delirium and Recovery Time-Richmond ScaleImmediately After extubationSedation and agitation will be assessed immediately after extubation using a second scale known as the Richmond Agitation-Sedation Scale (RASS). The RASS is on a scale of -5 to +4, with higher/more positive scores indicating worse outcomes (aka more aggressive behavior) and lower scores indicating better outcomes (less responsiveness). A score of 0(Zero) indicates a calm but alert patient.
Post-operative pain or complications0-1 hour post-operativePatients will recover for 1 hour in the post-anesthesia care unit, and a well-trained nurse blinded to the randomized study group will evaluate pain intensity by using the numeric rating scale (0-10 range, with higher scores indicating worse pain) at three intervals: immediately after arrival, 30 minutes after arrival, and 60 minutes after arrival. Any rescue analgesics that are administered will be documented. Patients will be observed postoperatively for any adverse events, as is standard procedure. Any other adverse features such as nausea, vomiting, or changes in vision or color will be followed for 30 days post procedure.

Countries

United States

Contacts

Primary ContactLeslie S Son, PhD
Lson@lsuhsc.edu225-765-7659
Backup ContactChristine LeBoeuf, DNP
christine.leboeuf@fmolhs.org225-765-7659

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026